XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Operating Activities          
Net income $ 123,604 $ 100,038 $ 357,216 $ 301,677  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation & amortization     21,746 21,994  
Increase in value of equity securities (1,020) (1,392) (1,224) (2,121)  
Increase in value of equity method investments     (10,708) (2,438)  
Amortization of securities, net     9,868 11,083  
Accretion of purchased loans     (3,883) (6,523)  
Share-based compensation     8,109 6,718  
Gain on assets     (2,143) (2,627)  
Gain on repurchase of subordinated debentures     (1,882) 0  
Provision for credit losses - loans 6,700 18,200 9,700 31,700  
Recovery of credit losses - unfunded commitments (1,000) 1,000 (1,000) 0  
Recovery of credit losses - investment securities (2,194) (330) (2,194) (330)  
Deferred income tax effect 2,229 (2,952) 7,659 686  
Increase in cash value of life insurance (1,404) (1,161) (4,661) (3,635)  
Originations of mortgage loans held for sale     (540,697) (467,339)  
Proceeds from sales of mortgage loans held for sale     475,426 477,185  
Changes in assets and liabilities:          
Accrued interest receivable     9,427 95  
Other assets     (29,654) (23,990)  
Accrued interest payable and other liabilities     9,471 43,405  
Net cash provided by operating activities     310,576 385,540  
Investing Activities          
Net decrease (increase) in federal funds sold     100 (1,325)  
Net increase in loans     (460,582) (428,985)  
Purchases of investment securities – available-for-sale     (80,116) (62,643)  
Proceeds from maturities of investment securities – available-for-sale     315,461 363,011  
Proceeds from maturities of investment securities – held-to-maturity     12,184 5,054  
Purchases of equity securities     (5,000) 0  
Redemption (purchase) of other investments     11,660 (445)  
Purchases for improvements to foreclosed assets     (2,925) 0  
Proceeds from sale of foreclosed assets     8,374 1,475  
Proceeds from sale of SBA loans     4,998 5,573  
Purchases of premises and equipment     (17,797) (24,277)  
Proceeds from sale of premises and equipment     14,475 14,818  
Return (purchase) of investment on cash value of life insurance, net     6,784 (1,218)  
Net cash used in investing activities     (192,384) (128,962)  
Financing Activities          
Net increase (decrease) in deposits     181,399 (82,001)  
Net (decrease) increase in securities sold under agreements to repurchase     (16,352) 37,331  
Decrease in FHLB and other borrowed funds     (50,250) (1,400,550)  
Increase in FHLB and other borrowed funds     0 1,400,000  
Retirement of subordinated debentures     (158,049) 0  
Proceeds from exercise of stock options, net     602 1,369  
Repurchase of common stock     (67,314) (84,036)  
Dividends paid on common stock     (117,655) (111,227)  
Net cash provided by financing activities     (227,619) (239,114)  
Net change in cash and cash equivalents     (109,427) 17,464  
Cash and cash equivalents – beginning of year     910,347 1,000,213 $ 1,000,213
Cash and cash equivalents – end of period $ 800,920 $ 1,017,677 $ 800,920 $ 1,017,677 $ 910,347